Acupuncture is effective for treating chemotherapy-induced peripheral neuropathy in cancer patients, conclude investigators from Hong Kong. In a randomised trial involving 87 patients, one arm received acupuncture twice weekly for eight weeks, while the other arm received standard care only. The acupoints used were standardised, reflecting a traditional Chinese medicine diagnosis of qi and Blood stagnation with accumulation of dampness, and according to the affected body area (for upper limbs Hegu L.I.-4, Quchi L.I.-11, Daling P-7, Weiguan SJ-5, and/or Baxie M-UE-22; for lower limbs Sanyinjiao SP-6, Zusanli ST-36, Taichong LIV-3, Jiexi ST-41, and/or Bafeng M-LE-8). Significant improvements were detected at eight weeks for pain, clinical neurological grading, quality of life and symptom distress. Improvements in pain interference, neurotoxicity-related symptoms and functional aspects of quality of life were sustained at 14-weeks, as were physical and functional well-being at 20-weeks.

A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy. Integr Cancer Ther. 2019 Jan-Dec;18:1534735419836501. doi: 10.1177/1534735419836501.